Genmab wisely chose not to pursue GEN3014 further, focusing instead on its existing pipeline projects. Click here to read an ...
Genmab A/S said that Johnson & Johnson has decided not to exercise its option to obtain a worldwide license for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback